epa_echo
1 records
fda
4 records
FDA Drug Recall: Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Ster
2023-10-04
Class III — Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.
View Source
FDA Drug Recall: Naftifine Hydrochloride Gel, USP 1%, packaged in cartons with: a) Net Wt. 90g tu
2022-08-10
Class II — Failed Impurities/ degradation specifications: Out-of-Specification test results obtained for Unspecified Impurity Relative Retention Time
View Source
FDA Drug Recall: Clindamycin and Benzoyl Peroxide Gel, 1%/5% 25 g jars, Rx only, Mfg by TOLMAR In
2021-12-22
Class II — Superpotent Drug
View Source
FDA Drug Recall: Ketoconazole Shampoo, 2%, Manufactured by TOLMAR Inc., Fort Collins, CO for Sand
2013-10-30
Class III — Subpotent
View Source
fda_adverse
1 records
ny_corps
2 records
NY Corp: TOLMAR ASSOCIATES LLC
2014-05-23
DOMESTIC LIMITED LIABILITY COMPANY | County: Nassau | Jurisdiction: New York
View Source
NY Corp: TOLMAR, INC.
2008-04-14
FOREIGN BUSINESS CORPORATION | County: Albany | Jurisdiction: Delaware
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.